167 related articles for article (PubMed ID: 30332421)
1. What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea.
Ronse M; Marí Sáez A; Gryseels C; Bannister-Tyrrell M; Delamou A; Guillard A; Briki M; Bigey F; Haba N; van Griensven J; Peeters Grietens K
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006885. PubMed ID: 30332421
[TBL] [Abstract][Full Text] [Related]
2. The Plasma Mobile, 'A gift from heaven': The impact of health technology transfer on trial perceptions and expectations during the Ebola-Tx Trial, Conakry.
Marí Sáez A; Ronse M; Delamou A; Haba N; Bigey F; van Griensven J; Peeters Grietens K
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008206. PubMed ID: 32320398
[TBL] [Abstract][Full Text] [Related]
3. Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.
Delamou A; Haba NY; Mari-Saez A; Gallian P; Ronse M; Jacobs J; Camara BS; Kadio KJO; Guemou A; Kolie JP; Crop M; Chavarin P; Jacquot C; Lazaygues C; Weggheleire A; Lynen L; van Griensven J
Am J Trop Med Hyg; 2016 Sep; 95(3):647-653. PubMed ID: 27430546
[TBL] [Abstract][Full Text] [Related]
4. The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.
van Griensven J; De Weiggheleire A; Delamou A; Smith PG; Edwards T; Vandekerckhove P; Bah EI; Colebunders R; Herve I; Lazaygues C; Haba N; Lynen L
Clin Infect Dis; 2016 Jan; 62(1):69-74. PubMed ID: 26261205
[TBL] [Abstract][Full Text] [Related]
5. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.
Edwards T; Semple MG; De Weggheleire A; Claeys Y; De Crop M; Menten J; Ravinetto R; Temmerman S; Lynen L; Bah EI; Smith PG; van Griensven J;
Clin Trials; 2016 Feb; 13(1):13-21. PubMed ID: 26768570
[TBL] [Abstract][Full Text] [Related]
6. What motivates individuals to volunteer in Ebola epidemic response? A structural approach in Guinea.
Kpanake L; Dounamou T; Sorum PC; Mullet E
Hum Resour Health; 2019 Nov; 17(1):81. PubMed ID: 31675955
[TBL] [Abstract][Full Text] [Related]
7. The Response to and Impact of the Ebola Epidemic: Towards an Agenda for Interdisciplinary Research.
Calnan M; Gadsby EW; Kondé MK; Diallo A; Rossman JS
Int J Health Policy Manag; 2018 May; 7(5):402-411. PubMed ID: 29764104
[TBL] [Abstract][Full Text] [Related]
8. Infectious diseases. Ebola survivors fight back in plasma studies.
Enserink M
Science; 2015 May; 348(6236):742-3. PubMed ID: 25977529
[No Abstract] [Full Text] [Related]
9. Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea.
Grantz KH; Claudot P; Kambala M; Kouyaté M; Soumah A; Boum Y; Juan-Giner A; Jemmy JP; Cummings DAT; Grais RF
Vaccine; 2019 Nov; 37(48):7165-7170. PubMed ID: 31623917
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States.
Dean CL; Hooper JW; Dye JM; Zak SE; Koepsell SA; Corash L; Benjamin RJ; Kwilas S; Bonds S; Winkler AM; Kraft CS
Transfusion; 2020 May; 60(5):1024-1031. PubMed ID: 32129478
[TBL] [Abstract][Full Text] [Related]
11. Profile and reintegration experience of Ebola survivors in Guinea: a cross-sectional study.
Delamou A; Camara BS; Kolie JP; Guemou AD; Haba NY; Marquez S; Beavogui AH; Delvaux T; van Griensven J
Trop Med Int Health; 2017 Mar; 22(3):254-260. PubMed ID: 27935657
[TBL] [Abstract][Full Text] [Related]
12. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of psychological distress and social support of survivors and contacts of Ebola virus disease infection and their relatives in Lagos, Nigeria: a cross sectional study--2014.
Mohammed A; Sheikh TL; Gidado S; Poggensee G; Nguku P; Olayinka A; Ohuabunwo C; Waziri N; Shuaib F; Adeyemi J; Uzoma O; Ahmed A; Doherty F; Nyanti SB; Nzuki CK; Nasidi A; Oyemakinde A; Oguntimehin O; Abdus-Salam IA; Obiako RO
BMC Public Health; 2015 Aug; 15():824. PubMed ID: 26307047
[TBL] [Abstract][Full Text] [Related]
14. A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors.
Holloway K; Campbell C; Ali R; Huyer LD; Hart D; Haw J; Brennenstuhl S; Grundy Q
Transfus Med; 2022 Oct; 32(5):351-365. PubMed ID: 35578828
[TBL] [Abstract][Full Text] [Related]
15. [Revival after Ebola: multidisciplinary assessment at 1 year, prospect and follow-up study of surviving patients from Ebola in Guinea (PostEboGui cohort)].
Msellati P; Touré A; Sow MS; Cécé K; Taverne B; Desclaux A; Barry M; Etard JF; Delaporte E;
Bull Soc Pathol Exot; 2016 Oct; 109(4):236-243. PubMed ID: 27704472
[TBL] [Abstract][Full Text] [Related]
16. Unintended consequences of the 'bushmeat ban' in West Africa during the 2013-2016 Ebola virus disease epidemic.
Bonwitt J; Dawson M; Kandeh M; Ansumana R; Sahr F; Brown H; Kelly AH
Soc Sci Med; 2018 Mar; 200():166-173. PubMed ID: 29421463
[TBL] [Abstract][Full Text] [Related]
17. [Ebola in Guinea: experience of stigma among health professional survivors].
Sow S; Desclaux A; Taverne B;
Bull Soc Pathol Exot; 2016 Oct; 109(4):309-313. PubMed ID: 27456158
[TBL] [Abstract][Full Text] [Related]
18. [Ebola contacts' surveillance: social impact and ethical issues in Senegal].
Desclaux A; Ndione AG; Badji D; Sow K
Bull Soc Pathol Exot; 2016 Oct; 109(4):296-302. PubMed ID: 26850106
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.
Brown JF; Dye JM; Tozay S; Jeh-Mulbah G; Wohl DA; Fischer WA; Cunningham CK; Rowe K; Zacharias P; van Hasselt J; Norwood DA; Thielman NM; Zak SE; Hoover DL
J Infect Dis; 2018 Jul; 218(4):555-562. PubMed ID: 29659889
[TBL] [Abstract][Full Text] [Related]
20. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
